Marker Therapeutics Inc (MRKR)

[Gatta-git-it]

While we continue to experience an almost daily erosion of investment/ownership money from a year ago high ~ $9.00..
... it is more than reasonable for Peter to update from the last data on July 22, 2019, 6 months ago on the 3 arm PC trial. Arm A 9 pts..1 CR, over half surpassed the median survival rate.. where are we 6 months later? Arm B, of 6, 3 improved, 3 declined, and arm C data mixed.. where are we 6 months later.
Where are we with the FDA approval for trials expansion?
Mr. CFO. What is the strategy of increasing the share price before another reverse split and dilutive financing with crazy warrant pricing, as in the two previous events?
With a few exceptions, the rest of us
seem to agree that from a business stand point ( and this IS a business) communications are among the worst.
Lastly, once again, the posting board has turned over from the most frequent posters. This is the third time I have seen this. Who remembers RW and Blu.. who remembers PL and machisti and others?

If this medical schools ( Baylor and Mayo) research and testing is not being accepted or others are becoming more successful quicker, wouldn't you want to know?
I'd be so very honored to apologize if data surpassed my concerns.. of course, I have posted this for 6 months.